JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 10, 2003; DOI: 10.1124/jpet.103.059931


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.059931v1
308/2/688    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobayashi, N.
Right arrow Articles by Takakura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, N.
Right arrow Articles by Takakura, Y.


Received for publication September 16, 2003.
Revised November 6, 2003.
Accepted for publication November 7, 2003.

Vector-based In Vivo RNA Interference: Dose- and Time-Dependent Suppression of Transgene Expression

Naoki Kobayashi 1*, Yumi Matsui 1, Atsushi Kawase 1, Kazuhiro Hirata 1, Makoto Miyagishi 2, Kazunari Taira 2, Makiya Nishikawa 1, Yoshinobu Takakura 1

1 Graduate School of Pharamceutical Sciences, Kyoto University 2 Department of Chemistry and Biotechnology, School of Engineering, the University of Tokyo

* Address correspondence to: E-mail: nkobayas{at}dds.pharm.kyoto-u.ac.jp

Abstract

RNA interference (RNAi) induced by delivery of a small interfering RNA (siRNA)-expressing vector was characterized in mice. siRNA-expressing plasmid DNA (pDNA) was injected by a hydrodynamics-based procedure along with pDNA encoding an exogenous target luciferase gene. A comparative study showed that stem-loop-type siRNA-expressing pDNA was superior, in terms of the transgene suppressive efficacy, to the tandem-type in the liver following systemic delivery of these pDNAs. Transgene suppression occurred in the liver, kidney and lung as well as muscle. The degree of suppression was dependent on the dose of siRNA-expressing pDNA and the time at which transgene expression was determined following simultaneous injection of siRNA-expressing and target pDNAs. A reduction in transgene expression became apparent at 1 day after injection, while a lower degree of inhibition was obtained before this, as early as 6 hr even in mice treated with an excess of siRNA- expressing pDNA. These results suggest that delivery of siRNA-expressing pDNA requires a period of time for induction of RNAi. A study of sequential injections revealed that prior injection of siRNA-expressing pDNA produced a significant suppression for at least 1 day, which disappeared within 4 days. Confocal microscopic studies indicated that the localization of the cells with successful delivery of transgene was different between primary and secondary hydrodynamics-based injections, accounting for the less effective inhibition following the sequential injections. Taken together, these results demonstrate that vector-based in vivo RNAi is a dose- and time-dependent process and offers the possibility of suppressing endogenous targets in a variety of somatic cells.


Key words: RNA interference, U6 promoter, hydrodynamics-based procedure, luciferase, plasmid DNA, small interfering RNA


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Li, S. Koshy, and H. G. Folkesson
Involvement of {alpha}ENaC and Nedd4-2 in the conversion from lung fluid secretion to fluid absorption at birth in the rat as assayed by RNA interference analysis
Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L1069 - L1078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. Li and H. G. Folkesson
RNA interference for {alpha}-ENaC inhibits rat lung fluid absorption in vivo
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L649 - L660.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Hassan, Y. Tian, W. Zheng, H. Ji, K. Sandberg, and J. G. Verbalis
Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney
Physiol Genomics, May 11, 2005; 21(3): 382 - 388.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.